{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:02:18Z","timestamp":1794283338597,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Special Research in Subsidies for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00011-020-01401-6","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T05:02:25Z","timestamp":1599886945000},"page":"1181-1189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":352,"title":["The coagulopathy, endotheliopathy, and vasculitis of COVID-19"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"1401_CR1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0188","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020. https:\/\/doi.org\/10.1515\/cclm-2020-0188.","journal-title":"Clin Chem Lab Med"},{"key":"1401_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047407","author":"B Ren","year":"2020","unstructured":"Ren B, Yan F, Deng Z, Zhang S, Xiao L, Wu M, Cai L. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047407.","journal-title":"Circulation"},{"issue":"5","key":"1401_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023\u20136.","journal-title":"J Thromb Haemost"},{"key":"1401_CR4","doi-asserted-by":"crossref","unstructured":"Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020:blood.2020006000.","DOI":"10.1182\/blood.2020006000"},{"issue":"20","key":"1401_CR5","first-page":"30157","volume":"S0049\u20133848","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;S0049\u20133848(20):30157\u201362.","journal-title":"Thromb Res"},{"key":"1401_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2015432.","journal-title":"N Engl J Med"},{"issue":"20","key":"1401_CR7","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.","journal-title":"N Engl J Med"},{"issue":"6","key":"1401_CR8","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u2013e440440.","journal-title":"Lancet Haematol"},{"issue":"5","key":"1401_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","volume":"132","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology. 2020;132(5):1238\u201345.","journal-title":"Anesthesiology"},{"key":"1401_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30121-1","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020. https:\/\/doi.org\/10.1016\/S2665-9913(20)30121-1.","journal-title":"Lancet Rheumatol."},{"key":"1401_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-020-06059-6","volume":"28","author":"DE Leisman","year":"2020","unstructured":"Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;28:1\u20134. https:\/\/doi.org\/10.1007\/s00134-020-06059-6.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1401_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12916-020-01682-y","volume":"18","author":"V Opoka-Winiarska","year":"2020","unstructured":"Opoka-Winiarska V, Grywalska E, Roli\u0144ski J. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? BMC Med. 2020;18(1):214.","journal-title":"BMC Med"},{"key":"1401_CR13","doi-asserted-by":"crossref","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl\u00e9s-Cano E, Sattler L, Mertes PM, Meziani F, CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020:1\u201310.","DOI":"10.1007\/s00134-020-06062-x"},{"issue":"17","key":"1401_CR14","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, Du B, Qin Y, Gao P, Qin X, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.","journal-title":"N Engl J Med"},{"key":"1401_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15016","author":"C Nougier","year":"2020","unstructured":"Nougier C, Benoit R, Simon M, Desmurs-Clavel H, Marcotte G, Argaud L, David JS, Bonnet A, Negrier C, Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.15016.","journal-title":"J Thromb Haemost"},{"key":"1401_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004466","author":"TK Maatman","year":"2020","unstructured":"Maatman TK, Jalali F, Feizpour C, Douglas A 2nd, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreutz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med. 2020. https:\/\/doi.org\/10.1097\/CCM.0000000000004466.","journal-title":"Crit Care Med"},{"key":"1401_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14854","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14854.","journal-title":"J Thromb Haemost"},{"key":"1401_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14850","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14850.","journal-title":"J Thromb Haemost."},{"issue":"3","key":"1401_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/j.jvca.2019.10.016","volume":"34","author":"E Scala","year":"2020","unstructured":"Scala E, Coutaz C, Gomez F, Alberio L, Marcucci C. Comparison of ROTEM sigma to standard laboratory tests and development of an algorithm for the management of coagulopathic bleeding in a tertiary center. J Cardiothorac Vasc Anesth. 2020;34(3):640\u20139.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1401_CR20","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.7326\/M20-2003","volume":"6","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake JP, L\u00fctgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schr\u00f6der AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, P\u00fcschel K, Kluge S. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020;6:M20\u20132003. https:\/\/doi.org\/10.7326\/M20-2003.","journal-title":"Ann Intern Med"},{"key":"1401_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14844","author":"M Dolhnikoff","year":"2020","unstructured":"Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Nascimento Saldiva PH, Mauad T, Marcia NE. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14844.","journal-title":"J Thromb Haemost."},{"key":"1401_CR22","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2566","author":"SF Lax","year":"2020","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, Vander K, Bargfrieder U, Trauner M. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020. https:\/\/doi.org\/10.7326\/M20-2566.","journal-title":"Ann Intern Med"},{"key":"1401_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15353","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. COVID-19: ACE2 centric infective disease? Hypertension. 2020. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15353.","journal-title":"Hypertension"},{"key":"1401_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.thromres.2020.05.032","volume":"192","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle B. ADAMTS13 activity, von Willebrand factor, factor VIII and d-dimers in COVID-19 inpatients. Thromb Res. 2020;192:174\u20135.","journal-title":"Thromb Res"},{"issue":"25","key":"1401_CR25","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1182\/blood-2018-09-874552","volume":"133","author":"J Streetley","year":"2019","unstructured":"Streetley J, Fonseca AV, Turner J, Kiskin NI, Knipe L, Rosenthal PB, Carter T. Stimulated release of intraluminal vesicles from Weibel\u2013Palade bodies. Blood. 2019;133(25):2707\u201317.","journal-title":"Blood"},{"key":"1401_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13244","author":"A Huisman","year":"2020","unstructured":"Huisman A, Beun R, Sikma M, Westerink J, Kusadasi N. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2. Int J Lab Hematol. 2020. https:\/\/doi.org\/10.1111\/ijlh.13244.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"1401_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-020-2836-4","volume":"24","author":"P Keith","year":"2020","unstructured":"Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Version 2. Crit Care. 2020;24(1):128.","journal-title":"Crit Care."},{"key":"1401_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.thromres.2020.05.001","volume":"192","author":"U Zachariah","year":"2020","unstructured":"Zachariah U, Nair SC, Goel A, Balasubramanian KA, Mackie I, Elias E, Eapen CE. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: consider low volume plasma exchange and low dose steroid. Thromb Res. 2020;192:2.","journal-title":"Thromb Res"},{"key":"1401_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-020-09730-0","volume":"27","author":"DM Smadja","year":"2020","unstructured":"Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, Khider L, Hadjadj J, Goudot G, Debuc B, Juvin P, Hauw-Berlemont C, Augy JL, Peron N, Messas E, Planquette B, Sanchez O, Charbit B, Gaussem P, Duffy D, Terrier B, Mirault T, Diehl JL. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020;27:1\u201310. https:\/\/doi.org\/10.1007\/s10456-020-09730-0.","journal-title":"Angiogenesis"},{"issue":"1","key":"1401_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16.","journal-title":"Crit Care"},{"issue":"4","key":"1401_CR31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1172\/JCI97488","volume":"128","author":"SJ Higgins","year":"2018","unstructured":"Higgins SJ, De Ceunynck K, Kellum JA, Chen X, Gu X, Chaudhry SA, Schulman S, Libermann TA, Lu S, Shapiro NI, Christiani DC, Flaumenhaft R, Parikh SM. Tie2 protects the vasculature against thrombus formation in systemic inflammation. J Clin Invest. 2018;128(4):1471\u201384.","journal-title":"J Clin Invest"},{"issue":"3","key":"1401_CR32","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","volume":"3","author":"SM Parikh","year":"2006","unstructured":"Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. Version 2. PLoS Med. 2006;3(3):e46.","journal-title":"PLoS Med."},{"key":"1401_CR33","doi-asserted-by":"publisher","first-page":"105981","DOI":"10.1016\/j.rmed.2020.105981","volume":"167","author":"M Ding","year":"2020","unstructured":"Ding M, Zhang Q, Li Q, Wu T, Huang YZ. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19. Respir Med. 2020;167:105981.","journal-title":"Respir Med"},{"issue":"8","key":"1401_CR34","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575\u2013e582582.","journal-title":"Lancet Haematol"},{"issue":"11","key":"1401_CR35","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0000000000001853","volume":"44","author":"J Fisher","year":"2016","unstructured":"Fisher J, Douglas JJ, Linder A, Boyd JH, Walley KR, Russell JA. Elevated plasma angiopoietin-2 levels are associated with fluid overload, organ dysfunction, and mortality in human septic shock. Crit Care Med. 2016;44(11):2018\u201327.","journal-title":"Crit Care Med"},{"key":"1401_CR36","doi-asserted-by":"crossref","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020:S0049-3848(20)30120-1.","DOI":"10.1016\/j.thromres.2020.04.013"},{"issue":"1","key":"1401_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1620\/tjem.251.27","volume":"251","author":"M Yamaya","year":"2020","unstructured":"Yamaya M, Nishimura H, Deng X, Kikuchi A, Nagatomi R. Protease inhibitors: candidate drugs to inhibit severe acute respiratory syndrome coronavirus 2 replication. Tohoku J Exp Med. 2020;251(1):27\u201330.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"1401_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/jpet.107.130609","volume":"325","author":"MA Richardson","year":"2008","unstructured":"Richardson MA, Gupta A, O'Brien LA, Berg DT, Gerlitz B, Syed S, Sharma GR, Cramer MS, Heuer JG, Galbreath EJ, Grinnell BW. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. J Pharmacol Exp Ther. 2008;325(1):17\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"1401_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.09.042","volume":"171","author":"T Iba","year":"2018","unstructured":"Iba T, Levy JH, Hirota T, et al. Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis. Thromb Res. 2018;171:1\u20136.","journal-title":"Thromb Res"},{"key":"1401_CR40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713152","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Qu\u00e9r\u00e9 I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. 2020. https:\/\/doi.org\/10.1055\/s-0040-1713152.","journal-title":"Thromb Haemost."},{"key":"1401_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Alexia B, Sandri MT, Barco S, Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9\u201314.","journal-title":"Thromb Res"},{"key":"1401_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62.","journal-title":"Thromb Res"},{"key":"1401_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14893","author":"NT Connell","year":"2020","unstructured":"Connell NT, Battinelli EM, Connors JM. Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14893.","journal-title":"J Thromb Haemost"},{"key":"1401_CR44","doi-asserted-by":"publisher","first-page":"107602961988743","DOI":"10.1177\/1076029619887437","volume":"25","author":"JC Chang","year":"2019","unstructured":"Chang JC. Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis. Clin Appl Thromb Hemost. 2019;25:1076029619887437.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"1401_CR45","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/STROKEAHA.116.015677","volume":"48","author":"SR Williams","year":"2017","unstructured":"Williams SR, Hsu FC, Keene KL, Chen WM, Dzhivhuho G, Rowles JL 3rd, Southerland AM, Furie KL, Rich SS, Worrall BB, Sale MM. Genetic drivers of von Willebrand factor levels in an ischemic stroke population and association with risk for recurrent stroke. Stroke. 2017;48(6):1444\u2013500.","journal-title":"Stroke"},{"issue":"22","key":"1401_CR46","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMcpc2002418","volume":"382","author":"ME Sise","year":"2020","unstructured":"Sise ME, Baggett MV, Shepard JO, Stevens JS, Rhee EP. Case 17\u20132020: a 68-year-old man with Covid-19 and acute kidney injury. N Engl J Med. 2020;382(22):2147\u201356.","journal-title":"N Engl J Med"},{"issue":"20","key":"1401_CR47","first-page":"30400","volume":"S1072\u20137515","author":"FL Wright","year":"2020","unstructured":"Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC Jr. Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg. 2020;S1072\u20137515(20):30400\u20132.","journal-title":"J Am Coll Surg"},{"key":"1401_CR48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1709996","author":"HC Kwaan","year":"2020","unstructured":"Kwaan HC. Coronavirus disease 2019: the role of the fibrinolytic system from transmission to organ injury and sequelae. Semin Thromb Hemost. 2020. https:\/\/doi.org\/10.1055\/s-0040-1709996.","journal-title":"Semin Thromb Hemost"},{"key":"1401_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31103-X","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X.","journal-title":"Lancet"},{"issue":"10234","key":"1401_CR50","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417\u20138.","journal-title":"Lancet"},{"key":"1401_CR51","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.clim.2020.108487","volume":"29","author":"L Roncati","year":"2020","unstructured":"Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, Nasillo V, Manenti A, Maiorana A. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020;29:108487. https:\/\/doi.org\/10.1016\/j.clim.2020.108487.","journal-title":"Clin Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-020-01401-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T01:12:55Z","timestamp":1631409175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-020-01401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1007\/s00011-020-01401-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"27 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Iba T. has received a research grant from Japan Blood Products Organization and JIMRO. Connors JM. receives personal fees from Bristol-Meyer Squibb, Abbott, Portola, and research funding to the institution from CSL Behring. Levy JH serves on the Steering or Advisory Committees for Instrumentation Laboratories, Merck, Octapharma, and Leading Biosciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}